# Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection

> **NCT05088252** · NA · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 112 (actual)

## Conditions studied

- Pituitary Neoplasms

## Interventions

- **DRUG:** Desflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05088252
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-01
- **Primary completion:** 2022-05-10
- **Final completion:** 2022-05-31
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05088252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05088252, "Desflurane and Anesthesia Recovery Period in Endonasal Endoscopic Pituitary Adenoma Resection". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05088252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*